Q4 | Jotup

Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results

Retrieved on:

Thursday, February 4, 2021

Q3, Q4, fis, Service companies, Companies, Finance

We believe the results of our disciplined focus and execution are validated by our performance in Q4 2020, nearly doubling the year-over-year growth reported in Q3 2020.

Key Points:

We believe the results of our disciplined focus and execution are validated by our performance in Q4 2020, nearly doubling the year-over-year growth reported in Q3 2020.
Our 2021 strategy emphasizes our continued marketing focus to increase awareness of the Sientra brand among both women and surgeons.
Estimated miraDry segment net sales of approximately $4.8 million in the fourth quarter 2020, a 54% decrease compared to $10.4 million for the same period in 2019 and 22% sequential growth over the quarter ending September 30, 2020.
Sientraexpects to announce its full fourth quarter and fiscal year 2020 results in earlyMarch 2021and will host a conference that day to discuss those results.

Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast

Retrieved on:

Tuesday, February 2, 2021

Biotechnology, Technology, Other Health, Health, Other Science, Other Technology, Medical devices, Research, Infectious diseases, Nanotechnology, Science, Bruker, Q4, Science and technology

Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2020 financial results on Tuesday, February 16, 2021, before the market opens.

Key Points:

Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2020 financial results on Tuesday, February 16, 2021, before the market opens.
To listen to the webcast, investors can go to https://ir.bruker.com and click on the Q4 2020 Earnings Webcast hyperlink in the Events & Presentations section.
A slide presentation will be referenced during the webcast and will be posted to the Companys website shortly before the webcast begins.
Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-412-317-6702 (international) and referencing Brukers Fourth Quarter 2020 Earnings Conference Call.

Ingevity announces dates for fourth quarter and full year earnings release and webcast

Retrieved on:

Thursday, January 14, 2021

Ingevity Corporation (NYSE: NGVT) today announced that it will release its fourth quarter and full year earnings after the stock market close on Wednesday, Feb. 10, 2021.

Key Points:

Ingevity Corporation (NYSE: NGVT) today announced that it will release its fourth quarter and full year earnings after the stock market close on Wednesday, Feb. 10, 2021.
The company will host a live webcast on Thursday, Feb. 11, 2021, at 10 a.m. (Eastern Time) to discuss fourth quarter and full year 2020 fiscal results.
The webcast can be accessed through the investors section of Ingevitys website, or via this link: Ingevity Q4 and full year 2020 webcast .
Headquartered in North Charleston, South Carolina, Ingevity operates from 25 locations around the world and employs approximately 1,850 people.

Byrna Technologies Announces Record Sales for both the Fourth Quarter & Full Fiscal Year 2020

Retrieved on:

Friday, December 4, 2020

Lisle, Illinois, Navistar International, Q4, Companies

ANDOVER, Mass., Dec. 4, 2020 /PRNewswire/ --Byrna Technologies Inc. (OTCQB: BYRN) (CSE: BYRN) ("Byrna" or "the Company")reported record sales for the fiscal fourth quarter ended November 30, 2020 of approximately $11.1 million, up from $4.2 million in the third quarter (a 265% increase quarter over quarter).

Key Points:

ANDOVER, Mass., Dec. 4, 2020 /PRNewswire/ --Byrna Technologies Inc. (OTCQB: BYRN) (CSE: BYRN) ("Byrna" or "the Company")reported record sales for the fiscal fourth quarter ended November 30, 2020 of approximately $11.1 million, up from $4.2 million in the third quarter (a 265% increase quarter over quarter).
Domestic sales accounted for 91.2% of Byrna's fourth quarter sales with International Sales accounting for 8.8%.
In terms of sales channels, 85.2% of Byrna's fourth quarter sales were generated through Byrna's e-commerce website, 10.9% of fiscal fourth quarter sales were through Byrna's brick & mortar dealers and 3.9% of Q4 revenues came from sales to Law Enforcement.
This brought Byrna's 2020 full fiscal year sales to $16.7 million, an 1,800% increase from Byrna's 2019 fiscal full year sales of $924,000.

Colleen Johnston, Former TD Bank CFO, Joins Q4 Inc. Board of Directors

Retrieved on:

Thursday, May 21, 2020

Professional services, Technology, Other Technology, Finance, Networks, Banking, Corporate finance, Investment, Investor relations, Stock market, Q4

(Q4), a leading global provider of cloud-based investor relations solutions, announced today the appointment of Colleen Johnston to the companys board of directors, effective immediately.

Key Points:

(Q4), a leading global provider of cloud-based investor relations solutions, announced today the appointment of Colleen Johnston to the companys board of directors, effective immediately.
A proven leader in investor relations, Colleen brings decades of experience in banking and capital markets to Q4.
As Chief Financial Officer of TD Bank between 2005 and 2015, Colleen built out a robust IR program that brought accessibility, responsiveness and value-add to the investor and analyst community, making IR a competitive advantage for the Bank.
We are delighted to welcome Colleen as an independent director to the Q4 board, said Darrell Heaps, CEO of Q4.

Immunovia Provides Third Update During COVID-19 Pandemic

Retrieved on:

Wednesday, May 13, 2020

Articles, Health, Medicine, Gastrointestinal cancer, Pancreatic cancer, RTT, Pandemic, Coronavirus, Medical diagnosis, Q4

LUND, Sweden, May 13, 2020 /PRNewswire/ -- ImmunoviaAB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic.

Key Points:

LUND, Sweden, May 13, 2020 /PRNewswire/ -- ImmunoviaAB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic.
During these challenging times, Immunovia remains focused on the sales start of the first-to-market test for early diagnosis of pancreatic cancer, IMMray PanCan-d.
Due to the extension of the Emergency Order, Immunovia's lab located in Marlborough, Massachusetts will remain closed at this time.
As an effect of COVID-19, Immunovia is now forced to revise the company's timeline and sales start date for IMMray PanCan-d, now targeting Q4 2020.

Immunovia Provides Third Update During COVID-19 Pandemic

Retrieved on:

Wednesday, May 13, 2020

Articles, Health, Medicine, Gastrointestinal cancer, Pancreatic cancer, RTT, Pandemic, Coronavirus, Medical diagnosis, Q4

LUND, Sweden, May 13, 2020 /PRNewswire/ -- ImmunoviaAB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic.

Key Points:

LUND, Sweden, May 13, 2020 /PRNewswire/ -- ImmunoviaAB (publ) ("Immunovia") today provides an update on the actions that the company is taking in response to the coronavirus (COVID-19) pandemic.
During these challenging times, Immunovia remains focused on the sales start of the first-to-market test for early diagnosis of pancreatic cancer, IMMray PanCan-d.
Due to the extension of the Emergency Order, Immunovia's lab located in Marlborough, Massachusetts will remain closed at this time.
As an effect of COVID-19, Immunovia is now forced to revise the company's timeline and sales start date for IMMray PanCan-d, now targeting Q4 2020.

Vermillion Reports Fourth Quarter 2019 Financial Results

Retrieved on:

Thursday, March 26, 2020

Bloomfield, Connecticut, Cigna, Quarter, Q4, Companies

ET

Key Points:

ET
AUSTIN, Texas, March 26, 2020 (GLOBE NEWSWIRE) -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based womens health company focused on gynecologic disease, today reported its financial results for the fourth quarter and year ended December 31, 2019.
Year over Year Results Fourth Quarter 2019 versus Fourth Quarter 2018:
Year over Year Results Twelve Months of 2019 versus Twelve Months of 2018:
We have executed a preferred in-network contract agreement with CIGNA.
Revenue on a per test performed basis was $333 in the fourth quarter of 2019 compared to $345 in the third quarter of 2019, and $398 in Q4 of 2018, driven by patient pay in specific geographies.
The cash balance at December 31, 2019 was $11.7 million, Cash utilization in the fourth quarter of 2019 was $2.9M.

Husky Energy Reports 2019 Fourth Quarter and Annual Results

Retrieved on:

Thursday, February 27, 2020

Floating production storage and offloading, Offshore engineering, Oil storage, Petroleum production, Barrel, Terra Nova oil field, Terra Nova, Q4, Units of measurement, Measurement, Articles

3Including Superior Refinery rebuild costs of $48 million in Q4 2019 and $113 million in 2019; expected to be largely covered by insurance.

Key Points:

3Including Superior Refinery rebuild costs of $48 million in Q4 2019 and $113 million in 2019; expected to be largely covered by insurance.
The Chicago 3:2:1 crack spread averaged $12.06 US per barrel compared to $13.38 US per barrel in Q4 2018.
In the Montney Formation, six liquids-rich wells at Wembley were started up in the fourth quarter.
This takes into account the suspension of production-related operations in the fourth quarter on the partner-operated Terra Nova FPSO, in which Husky has a 13% working interest.

Ingevity reschedules dates for fourth quarter and full year earnings release and webcast

Retrieved on:

Friday, January 31, 2020

Other Natural Resources, Chemicals, Plastics, Other Energy, Manufacturing, Natural Resources, Energy, Other Manufacturing, New York Stock Exchange, Q4, Fiscal year

Due to increased investor interest, Ingevity Corporation (NYSE: NGVT) today announced that it has rescheduled the release of its fourth quarter and full year earnings to Monday, Feb. 3, 2020, prior to stock market open.

Key Points:

Due to increased investor interest, Ingevity Corporation (NYSE: NGVT) today announced that it has rescheduled the release of its fourth quarter and full year earnings to Monday, Feb. 3, 2020, prior to stock market open.
The company has also rescheduled the live webcast for Monday, Feb. 3, 2020, at 11 a.m. (Eastern Time) to discuss fourth quarter and full year 2019 fiscal results and 2020 fiscal year guidance.
The webcast can be accessed through the investors section of Ingevitys website, or via this link: Ingevity Q4 and full year 2019 webcast .
Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect, and enhance the world around us.